8/11/21-Medication for Addiction Treatment in Perinatal Substance Use (Opiods)

Presentation Resources:

• American College of Obstetrics & Gynecology. (2017). Opioid Use and Opioid Use Disorder in Pregnancy.
  https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy

• Behnke, M., Smith, V. C., & Committee on Substance Abuse. (2013). Prenatal substance abuse: Short- and long-term effects on the exposed fetus. Pediatrics, peds.2012-3931. doi:10.1542/peds.2012-3931
  https://pediatrics.aappublications.org/content/131/3/e1009

• Center for Behavioral Health Statistics and Quality. (2017). 2016 National Survey on Drug Use and Health: Detailed tables. Substance Abuse and Mental Health Services Administration, Rockville, MD. Retrieved from
  https://www.samhsa.gov/data/report/results-2016-national-survey-drug-use-and-health-detailed-tables

• Children and Family Futures

• Children and Family Futures. (2017). Collaborative values inventory. Retrieved from
  http://www.cffutures.org/files/cvi.pdf

• Ecker,J. et al. (2019). Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal- Fetal Medicine, American College of Obstetricians and Gynecologists

• Hsu, YJ et al. Integration of Buprenorphine Treatment with Primary Care: Comparative Effectiveness on Retention, Utilization, and Cost
  Abstract only

• Jones, H. et al. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320- 2331.
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073631/

• Jones HE, Fischer G, Heil SH, et al. Maternal Opioid Treatment: Human Experimental Research (MOTHER) – Approach, Issues, and Lessons Learned.
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497510/

• Milliren, C. E., Gupta, M., Graham, D. A., Melvin, P., Jorina, M., & Ozonoff, A. (2017). Hospital variation in neonatal abstinence syndrome incidence, treatment modalities, resource use,and costs across pediatric hospitals in the United States, 2013 to 20
  https://hosppeds.aappublications.org/content/8/1/15.long

• Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. (2015). Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology, 35(8), 650–655. doi:10.1038/jp.2015.36
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520760/

• SAMHSA. (2018). Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorders and Their Infants.
  https://store.samhsa.gov/sites/default/files/d7/priv/sma18-5054.pdf

• U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. (2020). Births: Final data for 2019. National Vital Statistics Reports, 59(1). Hyattsville, MD: National Center for Health Sta
  https://www.cdc.gov/nchs/data/nvsr/nvsr67/nvsr67_01_tables.pdf

• Velez, M. L., & Jansson, L. M. (2015). Perinatal addictions: Intrauterine exposures. Textbook of Addiction Treatment: International Perspectives, 2333–2363. doi:10.1007/978-88-470- 5322-9_100
  https://www.researchgate.net/publication/300184533_Perinatal_Perinatal_Addictions_Intrauterine_Exposures

• Young, J. L., & Martin, P. R. (2012). Treatment of opioid dependence in the setting of pregnancy. Psychiatric Clinics of North America, 35, 441-460.
  Abstract and Key Points only at https://www.psych.theclinics.com/article/S0193-953X(12)00025-1/pdf

Related Resources:

• Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study. Summary only:
  https://europepmc.org/article/med/31567599